A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia

Nature Medicine

Volumn 9, Issue 9, 2003, Pages 1180-1186

  Borsello, Tiziana ^a   Clarkel, Peter G H ^a   Hirt, Lorenz ^b   Vercelli, Alessandro ^a   Repici, Mariaelena ^a   Schorderet, Daniel F ^b   Bogousslavsky, Julien ^b   Bonny, Christophe ^b  

^a Dept Anat Pharmacol/Forensic Med ^*

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT; PEPTIDE DERIVATIVE; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; STROKE;

ANIMALIA;

EID: 0141724805     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm911     Document Type: Article

References (41)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587 (1995).
2. Namura, S. et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J. Neurosci. 18, 3659-3668 (1998).
3. Hara, H. et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94, 2007-2012 (1997).
4. Morris, D.C. et al. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke 32, 2635-2640 (2001).
5. Iadecola, C. & Alexander, M. Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14, 89-94 (2001).
6. Fink, K. et al. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18, 1071-1076 (1998).
7. Gladstone, D.J., Black, S.E. & Hakim, A.M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33, 2123-2136 (2002).
8. Brott, T. & Bogousslavsky, J. Treatment of acute ischemic stroke. N. Engl. J. Med. 343, 710-722 (2000).
9. Petty, M.A. & Wettstein, J.G. White matter ischaemia. Brain Res. Rev. 31, 58-64 (1999).
10. Imai, H., McCulloch, J., Graham, D.I., Masayasu, H. & Macrae, I.M. New method for the quantitative assessment of axonal damage in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 22, 1080-1089 (2002).
11. Dirnagl, U., Iadecola, C. & Moskowitz, M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391-397 (1999).
12. Zipfel, G.J., Babcock, D.J., Lee, J.M. & Choi, D.W. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J. Neurotrauma 17, 857-869 (2000).
13. Yam, P.S., Dunn, L.T., Graham, D.I., Dewar, D. & McCulloch, J. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20, 772-779 (2000).
14. Wu, D.C., Ye, W., Che, X.M. & Yang, G.Y. Activation of mitogen-activated protein kinases after permanent cerebral artery occlusion in mouse brain. J. Cereb. Blood Flow Metab. 20, 1320-1330 (2000).
15. Saporito, M.S. et al. Preservation of cholinergic activity and prevention of neuron death by CEP-1347/KT-7515 following excitotoxic injury of the nucleus basalis magnocellularis. Neuroscience 86, 461-472 (1998).
16. Savinainen, A., Garcia, E.P., Dorow,D., Marshall, J. & Liu, Y.F. Kainate receptor activation induces mixed lineage kinase-mediated cellular signaling cascades via postsynaptic density protein 95. J. Biol. Chem. 276, 11382-11386 (2001).
17. Yang, D.D. et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389, 865-870 (1997).
18. Kuan, C.Y. et al. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22, 667-676 (1999).
19. Behrens, A., Sibilia, M. & Wagner, E.F. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nat. Genet. 21, 326-329 (1999).
20. Bonny, C., Oberson, A., Negri, S., Sauser, C. & Schorderet, D.F. Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death. Diabetes 50, 77-82 (2001).
21. Barr, R.K., Kendrick, T.S. & Bogoyevitch, M.A. Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277, 10987-10997 (2002).
22. Vives, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017 (1997).
23. Steiner, D.F., Smeekens, S.P., Ohagi, S. & Chan, S.J. The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267, 23435-23438 (1992).
24. Brugidou, J., Legrand, C., Mery, J. & Rabie, A. The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. Biochem. Biophys. Res. Commun. 214, 685-693 (1995).
25. Bennett, B.L. et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98, 13681-13686 (2001).
26. 2+-mediated activation of c-Jun N-terminal kinase and nuclear factor kappa B by NMDA in cortical cell cultures. J. Neurochem. 71, 1390-1395 (1998).
27. Coffey, E.T., Hongisto, V., Dickens, M., Davis, R.J. & Courtney, M.J. Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons. J. Neurosci. 20, 7602-7613 (2000).
28. Cavigelli, M., Dolfi, F., Claret, F.X. & Karin, M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14, 5957-5964 (1995).
29. Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572 (1999).
30. Dawson, D.A., Wadsworth, G. & Palmer, A.M. A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain Res. 892, 344-350 (2001).
31. Iadecola, C., Zhang, F. & Xu, X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 268, R286-R292 (1995).
32. Hossmann, K.A. Glutamate-mediated injury in focal cerebral-ischemia - the excitotoxin hypothesis revised. Brain Pathol. 4, 23-36 (1994).
33. Hardingham, G. E. & Bading, H. The yin and yang of NMDA receptor signalling. Trends Neurosci. 26, 81-89 (2003).
34. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
35. Curtis, J. & Finkbeiner, S. Sending signals from the synapse to the nucleus: possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth. J. Neurosci. Res. 58, 88-95 (1999).
36. Schauwecker, P.E. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res. 884, 116-128 (2000).
37. Zhu, X. et al. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435-441 (2001).
38. Kim, H.S. et al. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB J. 14, 1508-1517 (2000).
39. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
40. Huang, Z. etal. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885 (1994).
41. Ma, J., Qiu, J., Hirt, L., Dalkara, T. & Moskowitz, M.A. Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemia. Br. J. Pharmacol. 133, 345-350 (2001).